Literature DB >> 17641858

Inhibitory effect of curcumin on proliferation of human pterygium fibroblasts.

Mingchang Zhang1, Fang Bian, Chenting Wen, Nian Hao.   

Abstract

In order to investigate the effect of curcumin on proliferation and apoptosis of human pterygium fibroblasts (HPF) in culture and search for a new method to prevent the recurrence after pterygium surgery, HPF was incubated with 0-160 micromol/L curcumin for 24-96 h. The MTT method was used to assay the biologic activities of curcumin at different time points and different doses. The expression of proliferating cell nuclear antigen (PCNA) in each group was detected by immunohistochemistry. The cell cycle distribution was detected by flow cytometry (FCM). Administration of 20-80 micromol/L curcumin for 24-72 h could significantly inhibit HPF proliferation in a dose-and time-dependent manner (P<0.05). After treatment with curcumin at different concentrations of 20, 40, 80 and 160 micromol/L for 24 h, FCM revealed there was a significant sub-G1 peak at each concentration. The number of HPF in G0/G1 phase was increased, while in S phase, it was decreased (P<0.05). At the concentration of 20-80 micromol/L, curcumin, in a dose-dependent manner (P<0.05), could inhibit the expression of PCNA in HPF. It was suggested that curcumin could significantly inhibit the proliferation of HPF, make HPF arrest in G0/G1 phase and induce the apoptosis of HPF in a dose-and time-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641858     DOI: 10.1007/s11596-007-0332-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  The pathogenesis of pterygia.

Authors:  M T Coroneo; N Di Girolamo; D Wakefield
Journal:  Curr Opin Ophthalmol       Date:  1999-08       Impact factor: 3.761

2.  Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts.

Authors:  Timothy M Nolan; Nick Di Girolamo; Minas T Coroneo; Denis Wakefield
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

3.  Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model.

Authors:  S Busquets; N Carbó; V Almendro; M T Quiles; F J López-Soriano; J M Argilés
Journal:  Cancer Lett       Date:  2001-06-10       Impact factor: 8.679

4.  Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision.

Authors:  D T Tan; S P Chee; K B Dear; A S Lim
Journal:  Arch Ophthalmol       Date:  1997-10

5.  Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells.

Authors:  L Moragoda; R Jaszewski; A P Majumdar
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

Review 6.  Biological activities of Curcuma longa L.

Authors:  C C Araújo; L L Leon
Journal:  Mem Inst Oswaldo Cruz       Date:  2001-07       Impact factor: 2.743

Review 7.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

Authors:  Y J Surh; K S Chun; H H Cha; S S Han; Y S Keum; K K Park; S S Lee
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

8.  Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2'-deoxyuridine, and cyclin D1 in mouse olfactory epithelium.

Authors:  Y Ohta; K Ichimura
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-11       Impact factor: 1.547

9.  Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.

Authors:  Bhupesh K Prusty; Bhudev C Das
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

10.  Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.

Authors:  Alok C Bharti; Nicholas Donato; Bharat B Aggarwal
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

  10 in total
  6 in total

1.  Inhibitory effect of PPARγ agonist on the proliferation of human pterygium fibroblasts.

Authors:  Yuan Zou; Mingchang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 2.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

3.  Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts.

Authors:  Cheng-Wei Lu; Ji-Long Hao; Lei Yao; Hai-Jun Li; Dan-Dan Zhou
Journal:  Int J Mol Med       Date:  2017-04-07       Impact factor: 4.101

Review 4.  Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Nour Jama Mukhtar; Wiley Zhang; Tayyab Hamid Malik; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Front Pharmacol       Date:  2017-02-14       Impact factor: 5.810

5.  Development and Characterization of Curcumin-Silver Nanoparticles as a Promising Formulation to Test on Human Pterygium-Derived Keratinocytes.

Authors:  Gianmarco Stati; Francesco Rossi; Thithawat Trakoolwilaiwan; Le Duc Tung; Stefanos Mourdikoudis; Nguyễn Thi Kim Thanh; Roberta Di Pietro
Journal:  Molecules       Date:  2022-01-03       Impact factor: 4.411

6.  Curcuma longa Is Able to Induce Apoptotic Cell Death of Pterygium-Derived Human Keratinocytes.

Authors:  Silvia Sancilio; Silvio Di Staso; Stefano Sebastiani; Lucia Centurione; Nick Di Girolamo; Marco Ciancaglini; Roberta Di Pietro
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.